Bone lead measured by X-ray fluorescence: epidemiologic methods.

por Hu, H, Aro, A, Rotnitzky, A
Publicado 1995

Measurement variability associated with KXRF bone lead measurement in young adults.

por Hoppin, J A, Aro, A, Hu, H, Ryan, P B
Publicado 2000

Validation of K-XRF bone lead measurement in young adults.

por Hoppin, J A, Aro, A C, Williams, P L, Hu, H, Ryan, P B
Publicado 1995

The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study.

por Tsaih, S W, Schwartz, J, Lee, M L, Amarasiriwardena, C, Aro, A, Sparrow, D, Hu, H
Publicado 1999

Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study.

por Tsaih, S W, Korrick, S, Schwartz, J, Lee, M L, Amarasiriwardena, C, Aro, A, Sparrow, D, Hu, H
Publicado 2001

SARS Knowledge, Perceptions, and Behaviors: a Comparison between Finns and the Dutch during the SARS Outbreak in 2003

por Vartti, A.-M., Oenema, A., Schreck, M., Uutela, A., de Zwart, O., Brug, J., Aro, A. R.
Publicado 2009

Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City.

por Hernandez-Avila, M, Gonzalez-Cossio, T, Palazuelos, E, Romieu, I, Aro, A, Fishbein, E, Peterson, K E, Hu, H
Publicado 1996

Flavonoids of Chromolaena odorata (L.) R.M.King & H.Rob. as potential leads for treatment against tuberculosis

por Omokhua-Uyi, A.G., Madikizela, B., Aro, A.O., Abdalla, M.A., Van Staden, J., McGaw, L.J.
Publicado 2023

Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women.

por Chuang, H Y, Schwartz, J, Gonzales-Cossio, T, Lugo, M C, Palazuelos, E, Aro, A, Hu, H, Hernandez-Avila, M
Publicado 2001

Life Style Intervention Improves Retinopathy Status—The Finnish Diabetes Prevention Study

por Aro, A., Kauppinen, A., Kivinen, N., Selander, T., Kinnunen, K., Tuomilehto, J., Keinänen-Kiukaanniemi, S., Lindström, J., Uusitupa, M., Kaarniranta, K.
Publicado 2019

How often atrial flutter and atrial fibrillation coexist? Results from a large nationwide ECG-based study

por Aro, A, Eyob-Fesseha, H, Haukka, J, Halminen, O, Putaala, J, Linna, M, Mustonen, P, Hartikainen, J, Airaksinen, J, Lehto, M
Publicado 2023

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?

por Luojus, A, Lehto, M, Halminen, O, Haukka, J, Aro, A L, Putaala, J, Linna, M, Mustonen, P, Kinnunen, J, Niemi, M, Hartikainen, J, Airaksinen, J E K
Publicado 2023

How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide re...

por Lehto, M, Luojus, A, Halminen, O, Haukka, J, Aro, A L, Putaala, J, Linna, M, Mustonen, P, Kinnunen, J, Niemi, M, Hartikainen, J, Airaksinen, K E J
Publicado 2023